Tree of Knowledge International Corp. (CSE:TOKI; OTC:TRKWF) (the “Company” or “TOK”) (formerly Courtland Capital Inc.) is pleased to announce it has entered into a distribution agreement with Dr. Sanjay Gupta (the “Agreement”). Dr. Gupta, one of the most well-known medical professionals worldwide, joined the advisory board of TOK in July (see press release July 18, 2018). Through his work as President of the American Pain Association and other notable appointments he has access to a network of more than 160,000 medical professionals.

Pursuant to the Agreement, TOK will provide expertise in preparing formulations, manufacturing, production, inspection and packaging of a line of CBD and cannabis products for Dr. Gupta, as well as assist Dr. Gupta with labeling the products under Dr. Gupta’s name (the “Gupta Products”).  In addition, the Company will assist with product sales and distribution.  The new product line, branded under the name “Dr. Gupta’s” will include numerous products including, but not limited to, Premium Hemp Oil – CBD Capsules, CBD Tincture and CBD Salve.  These premium products will be non-GMO and gluten-free.  Under the Agreement, Dr. Gupta will own all the intellectual property associated with the Gupta Products, except for specific formulations prepared by TOK. The Agreement is for an initial term of two years and will automatically renew for successive additional one year periods so long as certain sales criteria are met.


Jean-Paul Gaillard, CEO of the Company stated:  “We are extremely excited that Dr. Gupta has selected TOK to work with to create a new product line under his name. We see this as an extraordinary partnership where we can combine our expertise in creating premium quality products with Dr. Gupta’s worldwide name recognition.  This is an important addition to our product pipeline.  Dr. Gupta’s global reach includes an extensive network of physicians, patients and followers.”

Dr. Sanjay Gupta stated: “As the world perception is changing with respect to CBD products, I have embraced Tree of Knowledge, first as an advisory member and now as a product partner.  Their vigorous testing and the exceptional quality of their products, being free of pesticides and microbial, makes them a world leader.  This level of quality allows me to offer my network of top medical professionals a line of products that they can be completely comfortable in recommending to their patients.”

ABOUT TREE OF KNOWLEDGE

The Company produces and sells hemp-based cannabidiol (‘CBD”) products in certain jurisdictions in the United States, as well as in Europe, South America, Australia and China.  Cannabidiol/CBD is a natural constituent of hemp which is purported to contain wellness properties. TOK’s CBD product line contains EVR Premium Hemp Oil, which is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound that is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States.  TOK currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.

For further information about TOK, please see the Company’s website at www.Evrcbd.com or contact the following:

Tree of Knowledge International Corp.

Michael Caridi, Chairman and CEO or

Tel: +1 (917) 295-1374

Michael@evrcbc.com

Daniel Caridi

Assistant to the Chairman

+1 (203) 969-5678

Daniel@evrcbd.com

Rahim Rajwani

Partner/Founder/Head of Compliance and Risk

Northbay Capital Partners Corp.

Suite 918-1030 West Georgia Street Vancouver, BC V6E 2Y3

M: 604.376.8821

T: 604.628.2661

www.northbaycapitalpartners.com

 

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Forward Looking Statements

This news release contains forward-looking statements relating to the proposed relationship between the Company and Dr. Gupta pursuant to the Agreement. There is no assurance that the product line will be successful or whether TOK will be able to realize all the expected benefits therefrom. These forward looking statements involve risks and uncertainties. Events or circumstances may cause actual results to differ materially from those anticipated as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company or the parties to the Agreement. These include legal and regulatory changes, the impact of general economic, industry and market conditions; expectations regarding market demand for particular products; the risks associated with product development and the impact of product competition. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by Management of the Company at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.  The forward-looking statements contained in this news release are made as of the date of this news release and Management of the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less